Healthcare Technology Report August 21, 2024

Roche has effectively acquired LumiraDx’s Point of Care technology, having obtained all necessary antitrust and regulatory clearances. Roche will integrate LumiraDx’s innovative multi-assay point-of-care platform into its global organization, enhancing its diagnostics portfolio. The platform consolidates a wide range of immunoassay and clinical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article